Exelixis, Inc. Banner Image

Exelixis, Inc.

  • Ticker EXEL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Exelixis, Inc. Logo Image
  • 51-200 Employees
  • Based in Alameda, California
Exelixis, Inc. engages in the discovery, development, and commercialization of small molecule drugs for the treatment of cancer, metabolic, and cardiovascular disorders. The company's compounds primarily target multiple receptor tyrosine kinases simultaneously.
Exelixis, Inc.

Most Recent Annual Report

Exelixis, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Exelixis, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports